4.6 Article

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Article Surgery

Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer

Hyeong Seok Kim et al.

Summary: The study found that serum CEA and CA19-9 had low sensitivity in diagnosing extrahepatic bile duct cancer (EBDC), limiting their usefulness as diagnostic biomarkers. CA19-9 had lower sensitivity for early stage cancer and N0 stage cancer compared to advanced stages.

BJS OPEN (2021)

Review Genetics & Heredity

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Jialing Liu et al.

Summary: Late-stage cancer metastasis is incurable in the clinic and is the leading cause of death in patients. Circulating tumor cells (CTCs), considered to be metastatic precursors shed from primary tumors, present challenges in isolation and characterization. Despite these difficulties, recent advancements in CTC isolation and culture techniques show promise for potential use as non-invasive biomarkers in predicting therapeutic response.

FRONTIERS IN GENETICS (2021)

Review Oncology

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer

Isabel Heidrich et al.

Summary: Colorectal cancer is a common malignancy with high mortality rates, often due to tumor cells spreading through the blood. Liquid biopsy, which analyzes circulating tumor cells and cell-free DNA in the blood, offers new diagnostic and therapeutic opportunities for colorectal cancer patients. It has the potential to improve early detection, monitor disease progression, and guide personalized treatment strategies.

CANCERS (2021)

Review Gastroenterology & Hepatology

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis

Oliver Clements et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Jesus M. Banales et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances

Alphonse E. Sirica et al.

HEPATOLOGY (2019)

Review Oncology

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Klaus Pantel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Surgery

Cholangiocarcinoma

Adeel S. Khan et al.

SURGICAL CLINICS OF NORTH AMERICA (2019)

Article Gastroenterology & Hepatology

Global trends and predictions in hepatocellular carcinoma mortality

Paola Bertuccio et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

Jesus M. Banales et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Oncology

Circulating tumor cells Exploring intratumor heterogeneity of colorectal cancer

Cristina Raimondi et al.

CANCER BIOLOGY & THERAPY (2014)

Article Medical Laboratory Technology

Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients

Eric Deneve et al.

CLINICAL CHEMISTRY (2013)

Article Surgery

Long-term Survival in Hilar Cholangiocarcinoma also Possible in Unresectable Patients

Anthony T. Ruys et al.

WORLD JOURNAL OF SURGERY (2012)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Surgery

Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution

Michelle L. DeOliveira et al.

ANNALS OF SURGERY (2007)

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Pathology

Frequent EpCam protein expression in human carcinomas

PT Went et al.

HUMAN PATHOLOGY (2004)

Review Gastroenterology & Hepatology

The epidemiology of cholangiocarcinoma

Y Shaib et al.

SEMINARS IN LIVER DISEASE (2004)

Article Multidisciplinary Sciences

Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood

YS Chang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)